dihexa parkinson's Growth factors and their peptide mimetics for treatment of traumatic brain injury Frontiers | Hepatocyte growth factor

Kaplin, A.I

[ 18 ] also showed no distinct adverse effects of the substance

A blood glucose level of 54 mg/dL or less was reported in 26% of patients receiving the 7 mg tablets, 30% of patients receiving the 14 mg tablets, and 32% with placebo

The FDA-approved, branded versions of GLP-1 products were so popular that the brand manufacturers were not able to keep up with demand, prompting the FDA to declare a shortage for each of the semaglutide and tirzepatide products over the course of 2022

So it sounds like going back to that example you said where maybe didnt work was the degenerative arthritis

Research from large-scale gene profiling studies suggests that GHK-Cu may regulate the activity of over 4,000 human genes reactivating those involved in tissue repair and regeneration while downregulating those associated with inflammatory and destructive processes